Priya Jain

Priya Jain has extensive experience in the field of pharmacovigilance and drug safety. Priya is currently serving as the VP, Head of Pharmacovigilance at Deciphera Pharmaceuticals since September 2021. Prior to this, they held the position of Sr. Director, Head of Pharmacovigilance at the same company from March 2019 to September 2021.

Before joining Deciphera Pharmaceuticals, Priya worked as the Medical Director, Drug Safety and Pharmacovigilance at Alkermes from June 2015 to March 2019. Priya also served as a Pharmacovigilance Scientist at ARIAD Pharmaceuticals, Inc. from June 2014 to June 2015.

Priya'sprevious experiences include working as the Manager, Pharmacovigilance and Drug Safety at TESARO, Inc. from September 2013 to May 2014. Priya also worked as a Senior Associate in Drug Safety and Pharmacovigilance at Asahi Kasei Pharma America from March 2012 to September 2013.

Priya's career in the field of drug safety and pharmacovigilance began as a Drug Safety Associate at PAREXEL from January 2011 to March 2012. Prior to that, they worked as a Senior CRA at Tufts-New England Medical Center from April 2008 to December 2010. Priya started their career as a Clinical Research Coordinator at Primary Care Cardiology Research from September 2005 to March 2008.

Priya Jain obtained their MBBS degree, which is equivalent to an MD, from Al-Ameen Medical College in India.